FDA recall, , Moderate risk
QuVa Pharma Methohexital Sodium
Methohexital Sodium failed impurities and degradation specifications.
Summary by Recall Canary from the FDA notice
What happened
QuVa Pharma, Inc., of Sugar Land, Texas, recalled Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, because it failed impurities and degradation specifications. The recall began June 24, 2026, and the product was distributed nationwide within the United States. The FDA added the recall to its Enforcement Report on July 7, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the list below, then check the codes the FDA notice also names.
A UPC is the number printed under a barcode.
Methohexital Sodium
- Strength
- 100 mg
- UPC
- 10162261
- 10162262
- 10162279
- 10162280
- 10162314
- 10162315
- 10162465
- 10162466
- 10162491
- 10162492
- 10162542
- 10162543
- 10162559
- 10162560
- 10162623
- 10162624
- 10162693
- 10162694
- 10162735
- 10162736
- 10162753
- 10162754
- 10162772
- 10162773
- 10162791
- 10162792
- 10162810
- 10162811
- 10162820
- 10162853
- 10162854
- 10163046
- 10163156
- 10163157
From the FDA notice
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46.
Recall details
- Company began the recall
- Sold in
Nationwide within the United States
- Company
- QuVa Pharma, Inc.Sugar Land, Texas
- Hazard
- Drug impurity
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99311
- Recall number
- D-0664-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
